Worth reading
59In focus
Scored from 2 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
0
Units (number exercised in October 2026)Wording
Definitive
How definitive the wording is.Details of issuance or disposal
Report on the monthly exercise status of stock acquisition rights with exercise price adjustment clauses
Intended allottee
Mizuho Securities Co., Ltd. (22nd Series Stock Acquisition Rights)
Terms of the stock acquisition rights
Exercise price
Minimum exercise price: ¥15,000. Policy not to activate the amendment provision for the Stage 5 minimum exercise price
Number of Stock Acquisition Rights
0 units exercised in October 2026. The total number issued and the number of outstanding unexercised rights are Not disclosed
Offering structure
Underwriter / lead underwriter
Mizuho Securities Co., Ltd.
Most recent equity financing
22nd Series Stock Acquisition Rights issued on 6 July 2026 (with an exercise price adjustment provision), 18th through 21st Series Stock Acquisition Rights issued on 6 July 2026 (with an exercise price adjustment provision), 23rd through 26th Series Stock Acquisition Rights issued on 6 July 2026 (fixed exercise price)
| Item | Details |
|---|---|
| Type of issuance or disposal | Report on the monthly exercise status of stock acquisition rights with exercise price adjustment clauses |
| Intended allottee | Mizuho Securities Co., Ltd. (22nd Series Stock Acquisition Rights) |
| Exercise price | Minimum exercise price: ¥15,000. Policy not to activate the amendment provision for the Stage 5 minimum exercise price |
| Number of Stock Acquisition Rights | 0 units exercised in October 2026. The total number issued and the number of outstanding unexercised rights are Not disclosed |
| Underwriter / lead underwriter | Mizuho Securities Co., Ltd. |
| Most recent equity financing | 22nd Series Stock Acquisition Rights issued on 6 July 2026 (with an exercise price adjustment provision), 18th through 21st Series Stock Acquisition Rights issued on 6 July 2026 (with an exercise price adjustment provision), 23rd through 26th Series Stock Acquisition Rights issued on 6 July 2026 (fixed exercise price) |
Items this document does not state (22)
Number of shares to be issued or disposed ofIssue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allottee's holding policyDilution RateTotal number of issued sharesBasis for determining the amount to be paidExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationOverallotmentStock Split RatioProcedures under the Corporate Code of ConductMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.It is stated that there were no exercises of the 22nd Series Stock Acquisition Rights in October 2026. With regard to the minimum exercise price, the policy is not to activate the amendment provision for the Stage 5 minimum exercise price, based on consideration for existing shareholders and strong confidence in further enhancing corporate value.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.